Transcatheter Aortic Valve Replacement (TAVR) has become one of the greatest innovations in structural heart treatment in the last ten years. Initially created as an alternative with regards to patients who might be perceived to be at high-risk due to certain factors like being considered high-risk to undergo open-heart surgery, TAVR has spread to